证券代码：688287 证券简称：观典防务 公告编号：2024-013 观典防务技术股份有限公司 关于收到独立董事督促函的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 "观典防务技术股份有限公司 2023 年度财务会计报告由大信会计师事务所出具带 保留意见的审计报告，并对公司内部控制审计报告出具否定意见，上海证券交易所已 就相关事项发出问询函。上海证券交易所还发布了 2023 年年度报告的信息披露监管问 询函。我们三位独立董事对此高度重视，本着勤勉履职、严格尽责的工作态度，专门 召开了独立董事会议，多次与公司管理层和董事会审计委员会、会计师事务所、券商 机构以及其他相关人员进行了深入沟通，并开展了详细的调查核实工作。 在此基础上，我们三位独立董事提出以下督促意见和整改措施，以促进企业合规 经营，切实维护全体股东、特别是中小股东的利益： （一）及时回复问询函： 我们督促公司全面、准确、及时地回复上海证券交易所《关于观典防务技术股份 有限公司 2023 年度审计报告涉及保留意见事项、内控审计报告涉及否定意见事项的问 询 ...

证券代码：688287 证券简称：观典防务 公告编号：2024-012 观典防务技术股份有限公司 关于收到上海证券交易所关于公司 2023 年年度报告的信息 披露监管问询函的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 观典防务技术股份有限公司（以下简称"公司"）于 2024 年 5 月 5 日收到上 海证券交易所（以下简称"上交所"）出具的《关于观典防务技术股份有限公司 2023 年年度报告的信息披露监管问询函》（上证科创公函【2024】0082 号）（以下简称 《问询函》），现将《问询函》具体内容公告如下： "观典防务技术股份有限公司： 依据《公开发行证券的公司信息披露内容与格式准则第 2 号——年度报告的 内容与格式》等规则的要求，我部对你公司 2023 年年度报告进行了事后审核。根 据《上海证券交易所科创板股票上市规则》第 14.1.1 条的规定，请你公司补充披 露下述信息。 一、关于货币资金及现金流 1、关于货币资金。公司 2023 年期初和期末货币资金分别为 4.17 亿元、1.88 亿元。其中，银行存款 ...

2024 年第一季度报告 证券代码：688287 证券简 称：观典防务 观典防务技术股份有限公司 2024 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 | | | 单位：元 | 币种：人民币 | | --- | --- | --- | --- | | | | | 本报告期比上 | | 项目 | 本报告期 | | 年同期增减变 | | | | | 动幅度(%) | | 营业收入 | | 47,947,956.58 | 11.20 | | 归属于上市公司股东的净 | | 5,883,786.17 | -31.25 | | 利润 | | | | | 归属 ...

Financial Performance - The corrected total operating revenue for 2023 is RMB 212.10 million, a decrease of RMB 58.72 million or 21.68% from the previous report[6] - The corrected operating profit is RMB 19.77 million, down by RMB 68.13 million or 77.50% compared to the prior figure[6] - The corrected total profit is RMB 23.76 million, reflecting a reduction of RMB 67.59 million or 73.99% from the initial report[6] - The net profit attributable to the parent company is corrected to RMB 25.02 million, a decrease of RMB 56.64 million or 69.36%[6] - The basic earnings per share is revised to RMB 0.07, down by RMB 0.15 or 68.18% from the previous estimate[6] Assets and Equity - Total assets at the end of the reporting period are RMB 1,115.14 million, an increase of 4.13% from the beginning of the period[4] - The equity attributable to the parent company is RMB 1,062.39 million, showing a slight increase of 0.65%[4] - The weighted average return on net assets decreased by 6.80 percentage points to 2.26%[4] Communication and Apologies - The company emphasizes the importance of prudent communication with auditors to ensure the accuracy of financial reports[8] - The company expresses sincere apologies for any inconvenience caused to investors due to the corrections made[10]

Investment Rating - The report initiates coverage with a "Buy" rating for the company [9][39]. Core Insights - The company is a national-level specialized "little giant" with distinctive drone manufacturing and operation capabilities, focusing on drone service and manufacturing, with each segment contributing approximately 50% to total revenue [1]. - The drone service segment has a high gross margin, with drug control services accounting for a significant portion of this business [1]. - The company has a strong competitive edge in the domestic drone drug control service market, leveraging first-mover advantages, extensive image data accumulation, and core algorithm iterations [1]. Summary by Sections Main Business - The company operates in two primary areas: drone service (including flight services and data processing) and drone system manufacturing, with each segment contributing roughly half to total revenue [1]. - The drone service business has a gross margin of about 60%, with drug control services making up 58% of this segment in 2021 [1]. Core Highlights - The integration of drones and data elements is expected to accelerate the company's expansion into multiple fields beyond drug control services, driven by the low-altitude economic wave [1]. - The company has established itself as a leading provider of drone drug control services, supported by three main advantages: first-mover advantage, extensive image data coverage, and continuous algorithm improvements [1]. - The drone flight service market shows potential for both volume and price increases, with the average bidding price for drug control services rising from 141 RMB to approximately 300 RMB per square kilometer [1][37]. - The company's core capabilities are replicable across various sectors, including agricultural protection and environmental monitoring, with the low-altitude economic trend further catalyzing this expansion [1][38]. Financial Characteristics - The company has demonstrated strong growth, with a compound annual growth rate (CAGR) of approximately 26% in profits over the past decade, maintaining a gross margin around 50% and a net margin above 30% [1]. - The financial forecasts predict net profits of 82 million, 107 million, and 140 million RMB for 2023, 2024, and 2025, respectively, with growth rates of 31% and 30.6% for the latter two years [8][39]. Investment Recommendations - The report anticipates revenue growth for the drone service business to exceed 20% annually from 2024 to 2025, driven by increased operational area and pricing [8]. - The company is compared favorably against peers in the A-share drone sector, with lower projected price-to-earnings (PE) ratios, suggesting a favorable investment opportunity [39].

重要内容提示： 观典防务技术股份有限公司（以下简称"公司"）于 2023 年 10 月 30 日在 上海证券交易所网站（http://www.sse.com.cn）披露了公司《2023 年第三季度 报告》，为便于广大投资者更全面深入地了解公司 2023 年第三季度的经营成果、 财务状况等情况，公司计划于 2023 年 11 月 30 日（星期四）15:00-16:00 召开 2023 年第三季度业绩说明会，就投资者关心的问题进行互动交流。 一、说明会类型 本次业绩说明会以网络互动形式召开，公司将针对 2023 年第三季度的经营 成果及财务指标的具体情况与投资者进行互动交流，在信息披露允许的范围内就 投资者普遍关注的问题进行解答。 证券代码：688287 证券简称：观典防务 公告编号：2023-029 观典防务技术股份有限公司 关于召开 2023 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 二、说明会召开的时间、地点和方式 （一）会议召开时间：2023 年 11 月 30 日（星期四）15:0 ...

Financial Performance - Q3 2023 revenue was CNY 44,496,325.20, a decrease of 29.86% compared to the same period last year[4] - Net profit attributable to shareholders was CNY 11,238,131.71, down 26.11% year-over-year[4] - Basic earnings per share for Q3 was CNY 0.03, a decline of 25.00% compared to the previous year[4] - Total operating revenue for the first three quarters of 2023 was CNY 211,316,919.59, a decrease of 3.9% compared to CNY 218,385,592.72 in the same period of 2022[16] - Net profit for the first three quarters of 2023 was CNY 73,474,133.72, a decline of 4.9% from CNY 77,255,669.35 in the previous year[18] - Basic and diluted earnings per share for the third quarter of 2023 were both CNY 0.20, compared to CNY 0.21 in the same quarter of 2022[18] Research and Development - R&D investment totaled CNY 7,535,919.67 in Q3, a decrease of 25.29%, but increased by 35.22% year-to-date[4][8] - The R&D investment as a percentage of revenue increased to 16.94%, up 1.04 percentage points from the previous year[5] - Research and development expenses increased to CNY 18,630,982.46 in the first three quarters of 2023, up from CNY 14,064,764.77, marking a rise of 32.5%[16] Cash Flow and Liquidity - The cash flow from operating activities showed a net decrease of 39.32% year-to-date, primarily due to reduced cash receipts from sales[8] - In the first three quarters of 2023, the cash inflow from operating activities was CNY 167,021,579.14, a decrease of 17.0% compared to CNY 201,452,476.95 in the same period of 2022[21] - The net cash flow from operating activities for the first three quarters of 2023 was CNY 34,736,021.23, down 39.3% from CNY 57,249,020.96 in the first three quarters of 2022[21] - The ending balance of cash and cash equivalents as of the end of the third quarter of 2023 was CNY 418,675,592.08, up from CNY 366,260,064.31 at the end of the third quarter of 2022[22] - The company received CNY 10,000,000.00 from investment recoveries in the first three quarters of 2023, a significant decline from CNY 179,000,000.00 in the same period of 2022[21] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,094,504,256.19, an increase of 5.27% from the previous year[5] - The company's current assets totaled ¥684,506,400.51, up from ¥607,301,366.72, indicating an increase of about 12.7% year-over-year[12] - Accounts receivable rose significantly to ¥184,027,956.40 from ¥118,120,498.42, representing a growth of approximately 55.8%[12] - The total liabilities decreased slightly to ¥684,506,400.51 from ¥607,301,366.72, showing a reduction of approximately 12.7%[12] - The total liabilities as of the end of the third quarter of 2023 were CNY 40,358,336.44, slightly down from CNY 40,479,282.45[14] Shareholder Information - Shareholders' equity attributable to shareholders was CNY 1,054,145,919.75, up 5.50% year-over-year[5] - The total number of ordinary shareholders at the end of the reporting period was 16,819[10] - The total equity attributable to shareholders of the parent company increased to CNY 1,054,145,919.75 from CNY 999,197,566.03, representing a growth of 5.5%[14] Financial Expenses - The company reported a financial expense of CNY -3,244,954.32, an improvement compared to CNY -5,069,342.14 in the previous year[16] Future Outlook - The company has not disclosed any new product developments or market expansion strategies in this quarter's report[12] - The company plans to continue focusing on market expansion and new product development in the upcoming quarters[20]

证券代码：688287 证券简称：观典防务 公告编号：2023-028 注册资本：37051.56 万元人民币 观典防务技术股份有限公司 关于完成工商变更登记及公司章程备案并取得营业执照的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 观典防务技术股份有限公司（以下简称"公司"）分别于 2023 年 8 月 21 日 及 2023 年 9 月 6 日召开了公司第三届董事会第二十次会议和 2023 年第一次临 时股东大会，审议通过了《关于变更公司注册资本、经营范围及修订<公司章程> 并办理工商变更登记的议案》。具体内容详见公司于 2023 年 8 月 22 日披露于上 海证券交易所网站（http://www.sse.com.cn）的《关于变更公司注册资本、经 营范围及修订<公司章程>并办理工商变更登记的公告》（公告编号：2023-014）， 以及于 2023 年 9 月 7 日披露的《2023 年第一次临时股东大会决议公告》（公告 编号：2023-023）。 近日，公司已完成工商变更登记手续和《公司章程》备案，并取得由 ...

证券代码：688287 证券简称：观典防务 观典防务 2023 年半年度业绩说明会 投资者关系活动记录表 编号：2023-003 | 投资者关系活动 | □ 特定对象调研 | □ 分析师会议 | □ 媒体采访 | ■ 业绩说明会 | | --- | --- | --- | --- | --- | | 类别 | □ 新闻发布会 □ 路演活动 | | □ 现场参观 | □ 其他 | | 形式 | □现场 ■网上 □电话会议 | | | | | 参与单位 | 线上参与公司 2023 年半年度业绩说明会的全体投资者 | | | | | 名称及人员姓名 | | | | | | 时 间 | 2023 年 10 月 10 日 14:00-15:00 | | | | | 地 点 | 价值在线（https://www.ir-online.cn/） 董事长兼总经理 高明 | | | | | | 副总经理兼董事会秘书 李振冰 | | | | | 上市公司 | 财务负责人 王彦 | | | | | 接待人员 | 独立董事 纪常伟 | | | | | | 保荐代表人 赵亮 | | | | | | 保荐代表人 纪若楠 | | | | ...

证券代码：688287 证券简称：观典防务 观典防务2023 年半年度业绩说明会 投资者关系活动记录表 编号：2023-003 投资者关系活动 □ 特定对象调研 □ 分析师会议 □ 媒体采访 ■ 业绩说明会 类别 □ 新闻发布会 □ 路演活动 □ 现场参观 □ 其他 形式 □现场 ■网上 □电话会议 参与单位 线上参与公司2023年半年度业绩说明会的全体投资者 名称及人员姓名 时 间 2023年10月10日 14:00-15:00 地 点 价值在线（https://www.ir-online.cn/） 董事长兼总经理 高明 副总经理兼董事会秘书 李振冰 财务负责人 王彦 上市公司 接待人员 独立董事 纪常伟 保荐代表人 赵亮 保荐代表人 纪若楠 投资者关系活动 1.公司曾在互动平台答复黄蜂t800的市场空间可达百亿，而公司今年推出新产品黄蜂 主要内容记录 t800后，上半年未体现业绩，目前该产品体量过小，请问预计何时能够对营收产生较大 ...